Health / Medical Topics

    2G-1 TCR Retroviral Vector-Transduced Lymphocytes

    A preparation of autologous human T-lymphocytes isolated from renal cell cancer (RCC) patient and transduced with 2G-1 TCR, a retroviral vector encoding the alpha and beta chains of a T-cell receptor that recognizes TNF-related apoptosis inducing ligand (TRAIL) bound to death receptor 4 (DR4), with potential immunostimulating and antineoplastic activities. After transduction, expansion in culture, and introduction into the RCC patient, 2G-1 TCR retroviral vector-transduced lymphocytes may stimulate a cytotoxic T lymphocyte (CTL) response against RCC cells with TRAIL bound to DR4 on their surfaces. TRAIL, a member of the TNF superfamily, is a homotrimeric type II membrane protein that rapidly induces oligomerization of receptor intracellular death domains and apoptosis in a variety of tumor cells when bound to its receptors; DR4 (TRAIL receptor 1), a member of the TNF receptor family, is overexpressed by a variety of malignant cell types. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    A chromosome band present on 22q
    The largest of the three RNA components of the mammalian ribosome.
    A drug pack that contains a 28 day supply of tablets, composed of a mixture of active and/or inert ingredient(s) that are…
    A synthetic peptide consisting of amino acids 27 through 35 of the melanoma differentiation antigen MART-1. 27-35(27L) MART-1 has a leucine substitution…
    Alternative splicing of the TREX2 gene results in five transcript variants. 26S Proteasome-Associated UCH Interacting Protein 1 results from use of…
    26S proteasome complex subunit DSS1 (70 aa, ~ 8 kDa) is encoded by the human SHFM1 gene. This protein is involved in…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact